TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible May 20, 1988